iCAN is a globally recognized Israeli company focused on the medical cannabis industry. iCAN is focused on developing novel cannabis formulations, devices and solutions to industry challenges. We are creating a portfolio of brands that will transform the global cannabis economy and ecosystem.
View Top Employees from iCAN: Israel-Cannabis| Website | http://www.israel-cannabis.com |
| Revenue | $3 million |
| Employees | 6 (6 on RocketReach) |
| Founded | 2015 |
| Address | Hauman 5, Bet Shemesh, Jerusalem, IL |
| Phone | +972 54-806-8613 |
| Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Banking, Biotechnology, Investment, Finance, Science and Engineering, Incubation, Cannabis, Funding, Community and Lifestyle, Community Building, Food and Beverage, Mentoring, Health Care, Event Management, Pharmaceutical, Branding, Marketing |
| SIC | SIC Code 611 Companies, SIC Code 61 Companies |
| NAICS | NAICS Code 52 Companies, NAICS Code 522 Companies, NAICS Code 5222 Companies |
Looking for a particular iCAN: Israel-Cannabis employee's phone or email?
iCAN: Israel-Cannabis Questions
The iCAN: Israel-Cannabis annual revenue was $3 million in 2023.
Debbie Kaye is the Assisant to Chief Executive Officer and Investor Relations of iCAN: Israel-Cannabis.
6 people are employed at iCAN: Israel-Cannabis.
iCAN: Israel-Cannabis is based in Bet Shemesh, Jerusalem.
The NAICS codes for iCAN: Israel-Cannabis are [52, 522, 5222].
The SIC codes for iCAN: Israel-Cannabis are [611, 61].
Top iCAN: Israel-Cannabis Employees
-
View
Debbie Kaye
Assisant to Chief Executive Officer and Investor Relations at iCAN: Israel-Cannabis
Tel Aviv District, Israel25+ -
ViewDaniel Goldstein
Senior Vice President Investments at iCAN: Israel-Cannabis
Tel Aviv-Yafo, Israel25 -
ViewJulia Weigensberg
Project Manager at Cannatech at iCAN: Israel-Cannabis
Los Angeles, California, United States22
